Biochemist, Chemist, Biotechnologist, Biochemical Engineer as Biologics Downstream Process Specialist, CMC (m/f/d)

Pieris Pharmaceuticals is a publicly traded biotechnology company (Nasdaq: PIRS) with operations in Germany and the United States, specializing in the discovery and development of anticalin-based drugs to address validated disease pathways individually and transformatively. Together with our partners, we carry out innovative research in the fields of immuno-oncology, respiratory diseases and ophthalmology. Pieris' proprietary Anticalin proteins are a novel class of drugs validated by clinical trials and partnerships with leading pharmaceutical companies.

To strengthen our team, we are looking for an experienced:

Biologics Downstream Process Specialist, CMC

Your Tasks:

  • Support process development, process fit analysis, technical transfer, scale-up and process validation at our CDMO sites.
  • Monitor, evaluate and maintain performance of downstream manufacturing at CDMOs. 
  • Maintain a strong working relationship with internal and external partners in the areas of trouble-shooting, technology review and new product manufacturing implementation.
  • Maintain keen technical familiarity with process and process equipment, process optimization evolution, and technical problem solving.
  • Author and review technical documents, protocols, reports, summaries, batch records and SOPs.
  • Author / review CMC sections and reports supporting regulatory filing.
  • Lead investigation into any purification related deviations.
  • Prepare management decisions and communicates project updates to the relevant project governance meetings and steering committee.
  • Identify, mitigate and if necessary, escalate project risks (quality, timeline, budget, scope) in downstream process development and manufacturing.
  • Complete all required training.
  • Provide support for upstream process development as needed.

Our Requirements:

  • Ph.D. or M.Sc. in biochemistry, chemistry, biotechnology, biochemical engineering, or a related discipline with 2 - 6 years of related experiences.
  • Comprehensive understanding of cGMP requirements for clinical and commercial biopharmaceutical manufacturing.
  • Experience in purification process development, process transfers, in support of cGMP manufacturing and technical trouble shooting.
  • Proficient with downstream operations such as centrifugation, filtration, chromatography, buffer preparation, cleaning and sanitization. Proficient with any in-process analysis needed to evaluate purification performance.
  • Experience in interfacing with health authorities on regulatory CMC filings and audits.
  • Demonstrated organizational skills and the ability to successfully manage multiple technical projects and priorities in a fast-paced environment.
  • Additional experience with USP is an advantage.
  • Strong technical writing and verbal communication skills are required.
  • Ability to travel is required.
We are a fast-growing biotechnology company with approximately 120 employees at our sites in Freising (Greater Munich Area) and Boston (USA). We work in flat hierarchies with short decision-making paths and offer a working environment characterized by cooperation and innovation.

Each of our employees participates directly in the success of the company through a stock option program and a stock savings plan. In addition, each employee participates in a bonus program based on the achievement of individual and company-wide goals. Creative employee events take place several times a year, as team spirit is essential for us. The joint creation of an innovative and participative corporate culture is an important concern for us.

While applying for the job please refer to jobvector

About PIERIS Pharmaceuticals GmbH

Pieris Pharmaceuticals GmbH is a subsidiary of Pieris Pharmaceutical Inc., a public US company. Pieris Pharmaceuticals GmbHis a clinical-stage biotechnology company advancing its proprietary Anticalin® technology to create differentiated drugs that are safer and more effective than conventional approaches. Exclusive to Pieris, Anticalin proteins promise to address high-unmet medical needs and...

More about PIERIS Pharmaceuticals GmbH